CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
February 2020—Qiagen introduced QIAseq Multimodal Panels, which offer a consolidated workflow to enrich DNA variants, RNA fusions, and gene expression levels from a single sample, with input as low as 10 ng of total nucleic acid. It reduces the workflow to approximately nine hours, the company reports, by eliminating the need for two workflows from separate DNA and RNA samples.
Laboratories will be able to interrogate samples for a range of nucleic acid biomarkers, such as single nucleotide variants, copy number variants, indels, RNA fusions, exon skipping events, and gene expression levels. This capability can be extended to applications such as tumor mutational burden and microsatellite instability profiling.
Pages: 1 2